Lv3
210 积分 2023-11-07 加入
53P Distinct cellular and molecular patterns in pre-treatment peripheral blood are associated with CAR-T outcomes in diffuse large B-cell lymphoma
3个月前
已关闭
Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy
3个月前
已关闭
Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy
3个月前
已完结
皖公网安备34019202002308
